E-Pub Full Text Articles

Identifying Patterns in Signs and Symptoms Preceding the Clinical Diagnosis of Alzheimer’s Disease: Retrospective Medical Record Review Study and a Nested Case-control Design

Author(s): Fidelia Bature*, Dong Pang, Anthea Robinson, Norma Polson, Yannis Pappas and Barbara Guinn
Pages: 1-8 (8)
Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

Author(s): M. A. Pappolla*, E. Matsubara, R. Vidal, J. Pacheco-Quinto, B. Poeggeler, M. Zagorski and K. Sambamurti
Pages: 1-1 (1)
Vascular Risk Factors and White Matter Hyperintensities as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment

Author(s): Raúl Romero-Sevilla*, Ignacio Casado-Naranjo, Juan Carlos Portilla-Cuenca, Beatriz Duque-de San Juan, José Manuel Fuentes and Fidel López-Espuela
Pages: 1-8 (8)
Tolfenamic Acid Prevents Amyloid β-Induced Olfactory Bulb Dysfunction In Vivo

Author(s): Cornejo-Montes-de-Oca Jose Maria, Hernandez-Soto Rebeca, Isla G. Arturo, C E Morado-Urbina and Pena-Ortega Fernando*
Pages: 1-12 (12)
Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer’s Disease

Author(s): Shohreh Majd * and John H.T Power
Pages: 1-13 (13)
Auditory Event-Related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease

Author(s): Cassandra Morrison *, Sheida Rabipour, Frank Knoefel and Christine Shepard
Pages: 1-10 (10)
Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease

Author(s): Antonio Martinez-Torteya, Hugo Gomez-Rueda, Victor Trevino, Joshua Farber, Jose Tamez-Pena* and For the Alzheimer’s Disease Neuroimaging Initiative
Pages: 1-13 (13)
Role of Nut Consumption in the Management of Cognitive Decline – A Mini-Review

Author(s): Blanka Klimova, Kamil Kuca*, Martin Valis and Jakub Hort
Pages: 1-6 (6)
Numeric, Agent-based or System Dynamics Model? Which Modeling Approach is the Best for Vast Population Simulation?

Author(s): Richard Cimler , Hana Tomaskova, Jitka Kuhnova, Ondrej Dolezal, Pavel Pscheidl and Kamil Kuca*
Pages: 1-9 (9)
Vitamin D and Subjective Memory Complaint in Community-Dwelling Older Adults

Author(s): Cedric Annweiler*, Lise Doineau , Lucie Gerigne , Anais Provendier , Spyridon N. Karras, Olivier Beauchet, Bruno Fantino and Guillaume T. Duval
Pages: 1-7 (7)
Drusen in the Peripheral Retina of the Alzheimer’s Eye

Author(s): Kresimir Ukalovic, Sijia Cao, Sieun Lee, Qiaoyue Tang, Mirza Faisal Beg, Marinko V Sarunic, Ging-Yuek R Hsiung, Ian R Mackenzie, Veronica Hirsch-Reinshagen, Jing Z Cui and Joanne A Matsubara*
Pages: 1-8 (8)
Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

Author(s): Matthew Davis, Thomas O`Connell, Scott Johnson, Stephanie Cline*, Elizabeth Merikle, Ferenc Martenyi and Kit N. Simpson
Pages: 1-12 (12)
Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital- based Cohort of Mild Cognitive Impairment Types

Author(s): Cecilia Camarda*, Carmela Pipia, Delia Azzarello, Iacopo Battaglini, Giovanni Romeo, Marcello Chiodi and Rosolino Camarda
Pages: 1-12 (12)
Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy

Author(s): J K Chang , A Leso , G M Subaiea, A Lahouel, A Masoud, F Mushtaq, R Deeb , A Eid, M Dash , S W Bihaqi and N H Zawia *
Pages: 1-8 (8)
AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival

Author(s): Naima Chalour*, Agathe Maoui*, Patrice Rat, France Massicot, Melody Dutot, Anne-Marie Faussat, Estelle Devevre, Astrid Limb, Jean-Michel Warnet, Jacques Treton, Virginie Dinet and Frederic Mascarelli
Pages: 1-12 (12)
(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer’s Disease

Author(s): Robert E. Becker*, Nigel H. Greig, Debomoy K. Lahiri, Joseph Bledsoe, Sarah Majercik, Clive Ballard, Dag Aarsland, Lon S. Schneider, Douglas Flanagan, Ramprakash Govindarajan, Mary Sano, Luigi Ferrucci and Dimitrios Kapogiannis
Pages: 1-9 (9)
Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers

Author(s): Olivier Vercruysse, Claire Paquet, Audrey Gabelle, Xavier Delbeuck, Frederic Blanc, David Wallon, Julien Dumurgier, Eloi Magnin, Olivier Martinaud, Barbara Jung, Olivier Bousiges, Sylvain Lehmann, Constance Delaby, Muriel Quillard-Murain, Katell Peoc’h, Jean-Louis Laplanche, Elodie Bouaziz-Amar, Didier Hannequin, Bernard Sablonniere, Luc Buee, Jacques Hugon, Susanna Schraen, Florence Pasquier and Stephanie Bombois*
Pages: 1-10 (10)
Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer’s Disease Patients

Author(s): Giulia Maria Sancesario*, Marzia Nuccetelli, Andrea Cerri, Joshua Zegeer, Cinzia Severini, Maria Teresa Ciotti, Massimo Pieri, Alessandro Martorana, Carlo Caltagirone, Robert Nistico and Sergio Bernardini
Pages: 1-9 (9)
Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis

Author(s): Huifeng Zhang, Dan Liu, Huanhuan Huang, Yujia Zhao and Hui Zhou*
Pages: 1-8 (8)
Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection

Author(s): Hui Liu*, Golam T. Saffi*, Maryam S. Vasefi, Youngjik Choi, Jeff S. Kruk, Nawaz Ahmed, Nyasha Gondora, John Mielke, Zoya Leonenko and Michael A. Beazely*
Pages: 1-10 (10)
Autoimmunity and Frontotemporal Dementia

Author(s): Antonella Alberici*, Viviana Cristillo, Stefano Gazzina, Alberto Benussi, Alessandro Padovani and Barbara Borroni
Pages: 1-8 (8)
Treponema, Iron and Neurodegeneration

Author(s): A. Jolivet-Gougeon and M. Bonnaure Mallet
Pages: 1-7 (7)

E-Pub Full Text Articles

Identifying Patterns in Signs and Symptoms Preceding the Clinical Diagnosis of Alzheimer’s Disease: Retrospective Medical Record Review Study and a Nested Case-control Design

Melatonin Treatment Enhances Aβ Lymphatic Clearance in a Transgenic Mouse Model of Amyloidosis

Vascular Risk Factors and White Matter Hyperintensities as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment

Tolfenamic Acid Prevents Amyloid β-Induced Olfactory Bulb Dysfunction In Vivo

Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer’s Disease

Auditory Event-Related Potentials in Mild Cognitive Impairment and Alzheimer’s Disease

Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease

Role of Nut Consumption in the Management of Cognitive Decline – A Mini-Review

Numeric, Agent-based or System Dynamics Model? Which Modeling Approach is the Best for Vast Population Simulation?

Vitamin D and Subjective Memory Complaint in Community-Dwelling Older Adults

Drusen in the Peripheral Retina of the Alzheimer’s Eye

Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia

Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital- based Cohort of Mild Cognitive Impairment Types

Tolfenamic Acid: A Modifier of the Tau Protein and its Role in Cognition and Tauopathy

AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival

(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer’s Disease

Relevance of Follow-Up in Patients with Core Clinical Criteria for Alzheimer Disease and Normal CSF Biomarkers

Bromelain Degrades Aβ1-42 Monomers and Soluble Aggregates: An In Vitro Study in Cerebrospinal Fluid of Alzheimer’s Disease Patients

Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis

Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection

Autoimmunity and Frontotemporal Dementia

Treponema, Iron and Neurodegeneration